On the occasion of the Aesthetics 2022 Congress held in Sydney, IBSA Derma launched its Profhilo® line on two new, high-potential markets: Australia and New Zealand.
In fact, considering the success achieved in the UK, United Arab Emirates, Singapore, Brazil and 75 other countries around the globe, landing on markets like these represents a unique, world-wide opportunity for IBSA to foster that model of authentic beauty that makes us unique and irreplaceable.
During a tour that touched the cities of Sydney, Melbourne and Adelaide, IBSA presented its innovative products and technologies to industry professionals and to several hundred scientific and business partners, valuably supported by several international and regional KOLs as Mr Dalvi Humzah, Dr. Gabriel Siquier, Dr. Cara MC Donald, Dr. Steven Liew and Dr. Robin Chock. In particular, emphasis was placed on the importance of the patented NAHYCO® technology, the current global benchmark for bio-remodelling of face and body skin laxity.